Physician profile
Jinli Wu
NPI 1679022180
$3,813.05
in general payments reported to CMS, 2019-2025
20 companies · $1,757 in 2025
The $1,757 reported for 2025 was more than what 89% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $23.65 · 2024: $2,032 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,773 · Entertainment: $39.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,773.43 |
| Entertainment | $39.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $935.22 | 2024-2025 | |
| Galderma Laboratories, L.P. | $779.97 | 2024-2025 | Dysport, Aklief |
| Revance Therapeutics, INC. | $605.26 | 2025 | Daxxify |
| Incyte Corporation | $345.80 | 2024-2025 | Opzelura |
| Dermavant Sciences, INC. | $222.43 | 2024 | Vtama |
| Regeneron Healthcare Solutions, INC. | $134.04 | 2024-2025 | Dupixent |
| Leo Pharma INC. | $123.26 | 2024 | Adbry |
| Musculoskeletal Transplant Foundation INC. | $110.76 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $101.40 | 2024-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $87.02 | 2024 | Zoryve |
| Journey Medical Corporation | $72.05 | 2024 | |
| Mayne Pharma Commercial LLC | $71.02 | 2025 | |
| Ucb, INC. | $42.39 | 2024 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $41.36 | 2024 | |
| Genzyme Corporation | $33.83 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $24.29 | 2024 | Siliq |
| Pfizer INC. | $23.65 | 2023 | Eucrisa, Cibinqo |
| Sun Pharmaceutical Industries INC. | $22.01 | 2025 | |
| Organon LLC | $19.16 | 2025 | Vtama |
| Strata Skin Sciences, INC. | $18.13 | 2025 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinli Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.